Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Topical quinolone antibacterial Zebiax launched in Japan

Jan. 12, 2016

Anacor submits NDA for crisaborole for atopic dermatitis

Jan. 8, 2016

Genetic association meta-analysis identifies 10 novel risk loci for atopic dermatitis

Jan. 8, 2016

Vitae initiates proof-of-concept study of VTP-38543 in atopic dermatitis

Dec. 30, 2015

Amarantus requests rare pediatric disease and orphan drug designations

Dec. 30, 2015

Revance's RT-001 reduces sweating in phase II axillary hyperhidrosis study

Dec. 28, 2015

AntibioTx advances preclinical development of dermal formulation of ATx-201

Dec. 23, 2015

Brickell Biotech reports data from phase IIb BBI-4000 trial in hyperhidrosis

Dec. 22, 2015

FDA grants orphan drug designation to cromolyn sodium (inhaled) for mastocytosis

Dec. 15, 2015

Mitsubishi Tanabe Pharma discloses MC1 receptor agonists

Dec. 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...